| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3127008
Max Phase: Preclinical
Molecular Formula: C31H35NO6
Molecular Weight: 517.62
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCN(CCCCCCOc1cc(O)c2c(=O)c(-c3ccc(O)cc3)coc2c1)Cc1ccccc1OC
Standard InChI: InChI=1S/C31H35NO6/c1-3-32(20-23-10-6-7-11-28(23)36-2)16-8-4-5-9-17-37-25-18-27(34)30-29(19-25)38-21-26(31(30)35)22-12-14-24(33)15-13-22/h6-7,10-15,18-19,21,33-34H,3-5,8-9,16-17,20H2,1-2H3
Standard InChI Key: ONQKJLHUNHPZMA-UHFFFAOYSA-N
Associated Targets(Human)
Acetylcholinesterase 18204 Activities
Associated Targets(non-human)
Butyrylcholinesterase 745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acetylcholinesterase 12221 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Acetylcholinesterase 2577 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 517.62 | Molecular Weight (Monoisotopic): 517.2464 | AlogP: 6.34 | #Rotatable Bonds: 13 |
| Polar Surface Area: 92.37 | Molecular Species: BASE | HBA: 7 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 7.31 | CX Basic pKa: 8.65 | CX LogP: 5.35 | CX LogD: 5.24 |
| Aromatic Rings: 4 | Heavy Atoms: 38 | QED Weighted: 0.20 | Np Likeness Score: 0.06 |
References
| 1. Qiang X, Sang Z, Yuan W, Li Y, Liu Q, Bai P, Shi Y, Ang W, Tan Z, Deng Y.. (2014) Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease., 76 [PMID:24589487] [10.1016/j.ejmech.2014.02.045] |
Source
Source(1):